Xenon’s seizure drug study reads out soon. Here’s what to expect Plus: An appreciation for retiring Alkermes CEO Richard Pops By Adam FeuersteinFeb. 26, 2026 Senior Writer, Biotech

https://www.statnews.com/2026/02/26/xenon-seizures-azetukalner-richard-pops-alkermes/